Thomas F Baumert

37PUBLICATIONS
135CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyRespiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jul 07, 2026
Humanized anti-Claudin-1 antibodies to treat colorectal cancer.

|Jun 16, 2026
High-fat, low-carb diet reduces tumor growth and induces liver metabolism remodeling in a breast cancer mouse model.

|Jun 03, 2026
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

|May 01, 2026
CT-based deep learning prediction of complete response in intermediate-stage hepatocellular carcinoma treated with drug-eluting beads transarterial chemoembolization.

|Mar 28, 2026
Hepatitis D Virus Pathogenesis: A Sense of Complications.

Yann Haennel, Thomas F Baumert, Joachim Lupberger

|Mar 02, 2026
Claudin proteins as emerging therapeutic targets for solid tumours.

Antonio Saviano, Alberto Toso, Samuel J Klempner

Pageof 7

Frequent Collaborators

10 joint publications

Joachim Lupberger

8 joint publications

Eloi R Verrier

7 joint publications

Yujin Hoshida

7 joint publications

Catherine Schuster